Stanley Druckenmiller acquired 593 Thousand Insmed shares worth $38.9 Million. That's 1.12% of their equity portfolio (27th largest holding). The first Insmed trade was made in Q2 2020. Since then Stanley Druckenmiller bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $42.1 Million, resulting in a loss of 7.4%.